MegaStats Cambridge Laboratories - Partners

Forging lasting partnerships

We believe that an open and honest working relationship is the key to success with all our partners - both with the major healthcare companies from whom we in-license or acquire products and our unique network of international distributors.

We have forged collaborations with many leading healthcare companies, including:

By focusing only on specialist pharmaceuticals in the secondary care sector, we are able to offer our licensees the benefits of a single-minded approach, backed by flexibility in terms of contractual arrangements. Just as importantly all our partnerships function well at a personal level, with a high level of trust and a willingness to collaborate to meet any challenges that the local market may present.

Partnerships in action - Xenazine

When Cambridge acquired the global rights to Xenazine from LifeHealth Limited in 1996 the product had received regulatory approval in just a handful of countries: Australia, Canada, Denmark, New Zealand and the UK.

We recognised Xenazine's global potential and, working with LifeHealth, we set about revitalising the product's pre-clinical, clinical, manufacturing and technical data... more